Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Clinical trial NCT03971461 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03971461
- Sponsor
- NYU Langone Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2025-04-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.